Loading...
Loading...
India's famotidine imports from UNITED STATES total $121.0K across 125 shipments from 15 foreign suppliers. SSS Pharmacy Inc leads with $30.9K in import value; the top 5 suppliers together control 74.7% of this origin. Leading Indian buyers include AUROBINDO PHARMA LTD. This corridor reflects India's pharmaceutical import demand for famotidine — a diversified sourcing base with multiple active suppliers from UNITED STATES.

SSS Pharmacy Inc is the leading Famotidine supplier from UNITED STATES to India, with import value of $30.9K across 2 shipments. The top 5 suppliers — SSS Pharmacy Inc, ESPEE BIOPHARMA & FINECHEM LLC, ENDO, AMNEAL PHARMACEUTICALS OF LLC, ENDO PHARMACEUTICALS SOLUTIONS INC. — collectively account for 74.7% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | SSS Pharmacy Inc | $30.9K | 2 | 25.5% |
| 2 | ESPEE BIOPHARMA & FINECHEM LLC | $28.2K | 5 | 23.3% |
| 3 | ENDO | $12.0K | 2 | 9.9% |
| 4 | AMNEAL PHARMACEUTICALS OF LLC | $10.6K | 3 | 8.8% |
| 5 | ENDO PHARMACEUTICALS SOLUTIONS INC. | $8.8K | 2 | 7.2% |
| 6 | RAFF & HALL PHARMACY | $7.1K | 2 | 5.9% |
| 7 | REGIONAL PHARMACY | $3.9K | 2 | 3.2% |
| 8 | AMSTERDAM PHARMA (APTEKA RX INC.) | $2.9K | 4 | 2.4% |
| 9 | EPIC PHARMA LLC | $2.1K | 2 | 1.7% |
| 10 | BILCARE GCS INC. | $2.0K | 1 | 1.7% |
| 11 | BIONPHARMA,INC. | $2.0K | 1 | 1.7% |
| 12 | M S NEW LIFE MEDICALS USA INC | $2.0K | 1 | 1.7% |
| 13 | NOVITIUM PHARMA LLC | $1.9K | 55 | 1.5% |
| 14 | NEWLIFE MEDICALS (USA). INC | $1.6K | 3 | 1.3% |
| 15 | GOOD HEALTH PHARMA SUPPLIES | $1.1K | 1 | 0.9% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | AUROBINDO PHARMA LTD | $31.7K | 10 | 26.2% |
| 2 | CENTAUR PHARMACEUTICALS PRIVATE LIMITED | $16.4K | 2 | 13.6% |
| 3 | PAR FORMULATIONS PRIVATE LIMITED | $12.0K | 3 | 9.9% |
| 4 | AXIS CLINICALS LIMITED | $10.8K | 3 | 8.9% |
| 5 | AMNEAL PHARMACEUTICALS PRIVATE LIMITED | $10.6K | 3 | 8.8% |
| 6 | MAIVA PHARMA PRIVATE LIMITED | $7.3K | 4 | 6.0% |
| 7 | ALEMBIC PHARMACEUTICALS LIMITED | $6.9K | 1 | 5.7% |
| 8 | CLIANTHA RESEARCH LIMITED | $4.9K | 2 | 4.0% |
| 9 | COPMED PHARMACEUTICALS PRIVATE LIMITED | $3.9K | 2 | 3.2% |
| 10 | CALLIDUS RESEARCH LABORATORIES PRIVATE LIMITED | $2.8K | 2 | 2.3% |
| 11 | NOVITIUM LABS PRIVATE LIMITED | $2.2K | 56 | 1.8% |
| 12 | MILAN LABORATORIES (INDIA) PRIVATE LIMITED | $2.0K | 1 | 1.7% |
| 13 | NUWILL RESEARCH AND INNOVATIONS PRIVATE LIMITED | $2.0K | 1 | 1.7% |
| 14 | RUBICON RESEARCH PRIVATE LIMITED | $2.0K | 1 | 1.7% |
| 15 | IPCA LABORATORIES LIMITED | $1.6K | 3 | 1.3% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Famotidine suppliers from UNITED STATES to India include SSS Pharmacy Inc, ESPEE BIOPHARMA & FINECHEM LLC, ENDO. The leading supplier is SSS Pharmacy Inc with import value of $30.9K USD across 2 shipments. India imported Famotidine worth $121.0K USD from UNITED STATES in total across 125 shipments.
India imported Famotidine worth $121.0K USD from UNITED STATES across 125 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Famotidine sourced from UNITED STATES include AUROBINDO PHARMA LTD, CENTAUR PHARMACEUTICALS PRIVATE LIMITED, PAR FORMULATIONS PRIVATE LIMITED. The largest buyer is AUROBINDO PHARMA LTD with $31.7K in imports across 10 shipments.
The total value of Famotidine imports from UNITED STATES to India is $121.0K USD, across 125 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
125 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists